FMT Could Prevent Hepatic Encephalopathy in Cirrhosis

A phase 2 trial of fecal microbiota transplantation to prevent hepatic encephalopathy in cirrhosis shows significant reduction in incidence, irrespective of delivery and number of doses.

Related Keywords

Boston ,Massachusetts ,United States ,Milan ,Lombardia ,Italy ,Jasmohan Bajaj ,Colleen Kelly ,School Of Medicine Internal ,Richmond Va Medical Center ,Harvard Medical School ,Virginia Commonwealth University ,Medicine Internal ,European Association ,Medscape Medical ,End Stage Liver Disease ,Sickness Impact Profile ,